title: Survival of patients evaluated for intestinal and multivisceral transplantation - the Scandinavian experience.
abstract: OBJECTIVE
  The current treatment of choice for patients with intestinal failure is parenteral nutrition, whereas medical therapy or resection is preferred for patients with neuroendocrine pancreatic tumors (NEPT) along with liver metastasis. As the survival of patients undergoing intestinal and multivisceral transplantation is improving, the discussion for expansion of treatment options has become a subject of debate. The aim was to investigate the outcome for patients referred for intestinal and multivisceral transplantation and to determine which patient group are the ones most likely to benefit the most from transplantation.
  
  
  METHODS
  The authors included all patients evaluated for intestinal and multivisceral transplantation at the Sahlgrenska University Hospital and The Queen Silvia Children's Hospital center between February 1998 and November 2009. Patients were classified according to proposed treatment strategy, and the outcome was evaluated.
  
  
  RESULTS
  A total of 43 adults and 19 children with either intestinal failure or NEPT with liver metastases were evaluated for transplantation. Of these patients, 15 adults and 5 children were transplanted. Transplantation was lifesaving for most children - all the children survived after transplantation, but 70% (4/6) died while awaiting transplantation. Among the adult patients with intestinal failure, the survival rate for patients considered to be stable on parenteral nutrition was higher than the transplanted adult patients. The survival rate of patients with NEPT was similar to the results seen among patients transplanted for intestinal failure.
  
  
  CONCLUSIONS
  The results confirm the poor prognosis of patients with intestinal failure awaiting transplantation and indicate that different transplantation criteria may be applied for adults and children, especially when early transplantation is the preferred treatment. The role of multivisceral transplantation in patients with NEPT remains uncertain.
authors.affiliation: Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden. jonas.varkey@vgregion.se
authors.forename: Jonas
authors.initials: J
authors.lastname: Varkey
authors.forename: Magnus
authors.initials: M
authors.lastname: Simrén
authors.forename: Ingvar
authors.initials: I
authors.lastname: Bosaeus
authors.forename: Marie
authors.initials: M
authors.lastname: Krantz
authors.forename: Markus
authors.initials: M
authors.lastname: Gäbel
authors.forename: Gustaf
authors.initials: G
authors.lastname: Herlenius
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D005260:Female; D006801:Humans; D007223:Infant; D007410:Intestinal Diseases / Q000150:complications / Q000601:surgery* / Q000628:therapy; D007422:Intestines / Q000637:transplantation*; D008297:Male; D008875:Middle Aged; D018358:Neuroendocrine Tumors / Q000150:complications / Q000601:surgery*; D009664:Norway; D016377:Organ Transplantation; D010190:Pancreatic Neoplasms / Q000150:complications / Q000601:surgery*; D010288:Parenteral Nutrition; D018579:Patient Selection; D012189:Retrospective Studies; D015996:Survival Rate; D013548:Sweden; D014781:Viscera / Q000637:transplantation*; D014850:Waiting Lists / Q000401:mortality; D055815:Young Adult